Nova Leap HealthNVLPF 50 5-Year Yield-on-Cost % is 0.00 as of Jul. 04, 2026. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.18 (Fairly Valued). The stock has 4 warning signs investors should review. Among 282 Healthcare Providers & Services companies, Nova Leap Health ranks worse than 354609.57% on this metric.
Nova Leap Health's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Nova Leap Health's 5-Year Yield-on-Cost % or its related term are showing as below:
NVLPF's 5-Year Yield-on-Cost % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 2.87 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Nova Leap Health (OTCPK:NVLPF) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Nova Leap Health 5-Year Yield-on-Cost % Related Terms
NVLPF vs HCA, THC, DVA: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, Nova Leap Health's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nova Leap Health 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Nova Leap Health's 5-Year Yield-on-Cost % falls into.
Nova Leap Health 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Nova Leap Health (NVLPF) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 04, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Nova Leap Health and its competitors. According to the industry distribution chart, Nova Leap Health ranks #999999 out of 282 companies in the Healthcare Providers & Services industry.
Is Nova Leap Health's 5-Year Yield-on-Cost % too high?
Nova Leap Health's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Nova Leap Health ranks #999999 out of 282 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's 5-Year Yield-on-Cost % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nova Leap Health ranks #999999 out of 282 companies for 5-Year Yield-on-Cost %. This places Nova Leap Health in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.87. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.87, based on 282 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Nova Leap Health and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova Leap Health's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Fairly Valued. The stock's GF Value™ is $0.18, compared to a current price of $0.25 — trading 36.9% above its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Nova Leap Health's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nova Leap Health (NVLPF) Overvalued in 2026?
Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued.
The current stock price of $0.25 is trading 36.9% above its estimated GF Value™ of $0.18.
GuruFocus considers Nova Leap Health to be Fairly Valued.
Key valuation signals for NVLPF:
5-Year Yield-on-Cost %: 0.00
GF Value™: $0.18 vs. price of $0.25 (36.9% above fair value)
No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score
Get the complete analysis for NVLPF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NVLPF has been successfully added to your 